Menu
  • Join
  • Login
  • Contact
 

Search abstracts


THE EFFICACY OF LINAGLIPTIN IN TYPE 2 DIABETES MELLITUS PATIENT WITH DIFFERENT RENAL INSUFFICIENT IN A REGIONAL HOSPITAL OF NORTHERN TAIWAN.

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Poster
  • By: WANG, Hsing-Hui (Sijhih Cathay General Hospital, Pharmacy, Taipei, China Taiwan)
  • Co-author(s): Yu-Li LIN
  • Abstract:

    Linagliptin is the first dipeptidyl peptidase-4 (DPP-4) inhibitor which does not need dose adjustiment in type 2 diabetes mellitus (T2DM) with any degree of renal function impairment because of hepatobiliary elimination.

    We retrospectively analyze data derived from a local hospital in the period of April 2013 till March 2015. According to renal

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses